STAT+: GLP-1s are given an FDA warning for rare eye condition risk
Verified: 10 outlets in 7 countries have reported this story since Nov 9, 2 of them from the United States.
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
2 outlets from the United States, where the story is: Ars Technica, STAT News · how we count
- Nov 9, 4:19 PM UTCFirst reportSTAT+: FDA warns GLP-1 drugs carry potential risk of rare eye conditionstatnews.com ↗
- Nov 9, 4:47 PM UTC+28 minFDA requires vision-loss warning on Novo Nordisk and Eli Lilly GLP-1 drugsinvesting.com ↗
- Nov 9, 9:58 PM UTC+6 hFDA adds rare vision-loss warning to popular GLP-1 weight loss drugsjamaica-gleaner.com ↗
- Nov 10, 3:01 PM UTC+23 h· you’re reading thisSTAT+: GLP-1s are given an FDA warning for rare eye condition riskstatnews.com (again) ↗
- Nov 10, 8:21 PM UTC+28 hMakers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindnessbbc.co.uk ↗
- Nov 10, 8:42 PM UTC+28 hFDA warns of rare eye condition causing blindness from GLP-1 weight loss medicationstheguardian.com ↗
- Nov 10, 8:44 PM UTC+28 hFDA warns of rare eye condition causing blindness from GLP-1 weight loss medicationstheguardian.com (again) ↗
- Nov 11, 9:19 AM UTC+41 hMakers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindnesskbc.co.ke ↗
No verification data yet
Checks run automatically as new sources are ingested.
Score bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this